EUVIMEDEUVIMED entdecken
Open Access

Discovery of novel dihydro-pyrimidine hybrids: insight into the design, synthesis, biological evaluation and absorption, distribution, metabolism and excretion studies

Uzma Arshad, Nusrat Shafiq iD, Shagufta Parveen iD, Maryam Rashid iD

Future Medicinal Chemistry · 2024

DOI: 10.1080/17568919.2024.2389767 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Future Medicinal Chemistry, 2024. Verfasst von Uzma Arshad und 3 weiteren Autor:innen. Beteiligte Einrichtung: Synthetic & Natural Products Discovery (SNPD) Laboratory, Department of Chemistry, Government College Women University, Faisalabad, 38000, Pakistan. Hauptthemen laut MEDLINE: Pyrimidines, Drug Design. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 123 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Higher Education Commission, Pakistan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

By keeping in aspects, the pharmacological potential of heterocyclic compounds, pyrimidine-based compounds were designed, synthesized and evaluated for α-amylase inhibitory potential.Materials & methods: Five new series 1a-l, 2a-d, 3a-d, 4a-d and 5a-d of 1,2,3,4-tetrahydroprimidine-5-carboxylate derivatives were designed by de novo method by taking Alogliptin as reference compound. Here in we describe synthesis and characterization of compounds as potential α-amylase inhibitor.

Results

Structure activity relationship (SAR), in vitro analysis and molecular modelling approaches generate compounds 1 h, 1i, 1k and 4c as potential lead with good α-amylase inhibitory selection. However, compound 1k failed the criteria of optimization as drug lead by ADME studies while all other compounds showed optimum range for all in silico ADME parameters.

Conclusion

Therefore, these compounds can serve as potential lead candidate in developing anti-diabetic therapy. [Box: see text].

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyrimidinesDrug DesignStructure-Activity RelationshipHumansalpha-AmylasesMolecular StructureHypoglycemic AgentsDrug DiscoveryEnzyme InhibitorsModels, MolecularAnimals

Stichwörter der Autor:innen

alogliptinhyperosmolar hyperglycemic syndrome (HHS)pharmacophorevogliboseα-amylase inhibition

Substanzen

Pyrimidinesalpha-AmylasesHypoglycemic AgentsEnzyme Inhibitorspyrimidine

Autor:innen und Institutionen

  • Synthetic & Natural Products Discovery (SNPD) Laboratory, Department of Chemistry, Government College Women University, Faisalabad, 38000, Pakistan.

ORCID-Profile: Nusrat Shafiq, Shagufta Parveen, Maryam Rashid

Förderung

  • Higher Education Commission, Pakistan

Zitieren

APA

Arshad, U., Shafiq, N., Parveen, S., & Rashid, M. (2024). Discovery of novel dihydro-pyrimidine hybrids: insight into the design, synthesis, biological evaluation and absorption, distribution, metabolism and excretion studies. Future Medicinal Chemistry. https://doi.org/10.1080/17568919.2024.2389767

Vancouver

Arshad U, Shafiq N, Parveen S, Rashid M. Discovery of novel dihydro-pyrimidine hybrids: insight into the design, synthesis, biological evaluation and absorption, distribution, metabolism and excretion studies. Future Medicinal Chemistry. 2024. doi:10.1080/17568919.2024.2389767

BibTeX
@article{Arshad2024,
  author = {Arshad, Uzma and Shafiq, Nusrat and Parveen, Shagufta and Rashid, Maryam},
  title = {Discovery of novel dihydro-pyrimidine hybrids: insight into the design, synthesis, biological evaluation and absorption, distribution, metabolism and excretion studies},
  journal = {Future Medicinal Chemistry},
  year = {2024},
  doi = {10.1080/17568919.2024.2389767}
}
Kostenlos starten →